psychedelic clinical trials

Articles tagged with “psychedelic clinical trials”

1 article

Compass Pathways: Extra COMP360 Dose Extends Relief to 1 Year

Compass Pathways reports 52-week open-label data from its COMP005 trial showing a second COMP360 psilocybin dose extended benefit. Here's what patients should know.

Sep 10, 2026

Read

Back to all articles

Need help or want to reach readers?

Have a correction, provider question, or advertising inquiry? Reach the editorial team.

Contact the site